Terms: = Liver cancer AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1
519 results:
1. Efficacy of radiofrequency ablation combined with sorafenib for treating liver cancer complicated with portal hypertension and prognostic factors.
Yang LM; Wang HJ; Li SL; Gan GH; Deng WW; Chang YS; Zhang LF
World J Gastroenterol; 2024 Mar; 30(11):1533-1544. PubMed ID: 38617449
[TBL] [Abstract] [Full Text] [Related]
2. Extraction-free, immuno-RPA-CRISPR/Cas13a-based one-pot detection of glypican-3 directly from extracellular vesicles.
Xiao X; Lin X; Ting CL; Huang X; Zeng B; Liu T; Zeng T
Anal Chim Acta; 2024 Apr; 1297():342385. PubMed ID: 38438232
[TBL] [Abstract] [Full Text] [Related]
3. Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma.
Lin F; Clift R; Ehara T; Yanagida H; Horton S; Noncovich A; Guest M; Kim D; Salvador K; Richardson S; Miller T; Han G; Bhat A; Song K; Li G
J Nucl Med; 2024 Apr; 65(4):586-592. PubMed ID: 38423788
[TBL] [Abstract] [Full Text] [Related]
4. Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs).
Patel KR; Espinoza AF; Urbicain M; Patel RH; Major A; Sarabia SF; Lopez-Terrada D; Vasudevan SA; Woodfield SE
Pathol Res Pract; 2024 Mar; 255():155163. PubMed ID: 38394806
[TBL] [Abstract] [Full Text] [Related]
5. Aptamer-bivalent-cholesterol-mediated proximity entropy-driven exosomal protein reporter for tumor diagnosis.
Fan Z; Zhou J; Shu Q; Dong Y; Li Y; Zhang T; Bai G; Yu H; Lu F; Li J; Zhao X
Biosens Bioelectron; 2024 May; 251():116104. PubMed ID: 38368644
[TBL] [Abstract] [Full Text] [Related]
6. GenX caused liver injury and potential hepatocellular carcinoma of mice via drinking water even at environmental concentration.
Wan G; Zhang Z; Chen J; Li M; Li J
Environ Pollut; 2024 Apr; 346():123574. PubMed ID: 38365076
[TBL] [Abstract] [Full Text] [Related]
7. Combination of serum alpha-fetoprotein, PIVKA-Ⅱ and glypican-3 in diagnosis of hepatocellular carcinoma: a meta-analysis.
Song H; Wang J; Zhang H; Wu Y; Wang K; Wang X; Xu X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 53(1):131-139. PubMed ID: 38310085
[TBL] [Abstract] [Full Text] [Related]
8. Smart glypican-3-targeting peptide-chlorin e6 conjugates for targeted photodynamic therapy of hepatocellular carcinoma.
Fang Y; Ma H; Zhang X; Zhang P; Li Y; He S; Sheng C; Dong G
Eur J Med Chem; 2024 Jan; 264():116047. PubMed ID: 38118394
[TBL] [Abstract] [Full Text] [Related]
9. WGCNA combined with machine learning to find potential biomarkers of liver cancer.
Lv JH; Hou AJ; Zhang SH; Dong JJ; Kuang HX; Yang L; Jiang H
Medicine (Baltimore); 2023 Dec; 102(50):e36536. PubMed ID: 38115320
[TBL] [Abstract] [Full Text] [Related]
10. Current methods for the detection of glypican-3.
Xiao X; Huang Q; Lin X; Zahid KR; Huang X; Liu T; Zeng T
Anal Methods; 2024 Jan; 16(2):152-160. PubMed ID: 38108085
[TBL] [Abstract] [Full Text] [Related]
11. The role and mechanism of HIF-1α-mediated glypican-3 secretion in hypoxia-induced tumor progression in hepatocellular carcinoma.
Wang P; Tong K; Li Y; Li X; Zhang Y; Gu J; Lei P; Yan S; Hu P
Cell Signal; 2024 Feb; 114():111007. PubMed ID: 38081444
[TBL] [Abstract] [Full Text] [Related]
12. Glutamine synthetase and hepatocellular carcinoma.
Jiang J; Hu Y; Fang D; Luo J
Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102248. PubMed ID: 37979911
[TBL] [Abstract] [Full Text] [Related]
13. Whole-genome sequencing and RNA sequencing analysis reveals novel risk genes and differential expression patterns in hepatoblastoma.
Wang W; Zhang N; Chen L; Zhao X; Shan Y; Yang F; Wang B; Gao H; Xu M; Tang P; Qin S; Gu S
Gene; 2024 Mar; 897():147991. PubMed ID: 37972697
[TBL] [Abstract] [Full Text] [Related]
14. Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study.
Zhang L; Su K; Liu Q; Li B; Wang Y; Cheng C; Li Y; Xu C; Chen J; Wu H; Zhu M; Mai X; Cao Y; Peng J; Yue Y; Ding Y; Yu D
BMC Cancer; 2023 Nov; 23(1):1081. PubMed ID: 37946141
[TBL] [Abstract] [Full Text] [Related]
15. gpc3 and PEG10 peptides associated with placental gp96 elicit specific T cell immunity against hepatocellular carcinoma.
Qin L; Wang J; Cheng F; Cheng J; Zhang H; Zheng H; Liu Y; Liang Z; Wang B; Li C; Wang H; Ju Y; Tian H; Meng S
Cancer Immunol Immunother; 2023 Dec; 72(12):4337-4354. PubMed ID: 37932427
[TBL] [Abstract] [Full Text] [Related]
16. gpc3-IL7-CCL19-CAR-T primes immune microenvironment reconstitution for hepatocellular carcinoma therapy.
Lu LL; Xiao SX; Lin ZY; Bai JJ; Li W; Song ZQ; Zhou YH; Lu B; Wu WZ
Cell Biol Toxicol; 2023 Dec; 39(6):3101-3119. PubMed ID: 37853185
[TBL] [Abstract] [Full Text] [Related]
17. The Role of microRNAs in Regulating cancer Cell Response to Oxaliplatin-Containing Regimens.
Tavakoli Pirzaman A; Ebrahimzadeh Pirshahid M; Babajani B; Rahmati A; Niknezhad S; Hosseinzadeh R; Taheri M; Ebrahimi-Zadeh F; Doostmohamadian S; Kazemi S
Technol Cancer Res Treat; 2023; 22():15330338231206003. PubMed ID: 37849311
[TBL] [Abstract] [Full Text] [Related]
18. Identification and validation of microtubule depolymerizing agent, CYT997, as a potential drug candidate for hepatocellular carcinoma.
Ahmad F; Ma L; Wei W; Liu Y; Hakim I; Daugherty A; Mujahid S; Radin AA; Chua MS; So S
Liver Int; 2023 Dec; 43(12):2794-2807. PubMed ID: 37833852
[TBL] [Abstract] [Full Text] [Related]
19. Interpretation of Farnesoid X Receptor Immunohistochemical Expression in Discriminating Hepatocellular Carcinoma from Its Non-Neoplastic Mimics as an Adjunct to Glypican 3.
Salama DEA; Shash LS; Shakweer MM; Abdel-Maqsoud RR; Ahmed Abosaif AI; Elgohary SA
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3221-3227. PubMed ID: 37774075
[TBL] [Abstract] [Full Text] [Related]
20. A novel bispecific antibody as an immunotherapeutic agent in hepatocellular carcinoma.
Liu Q; Song Q; Luo C; Wei J; Xu Y; Zhao L; Wang Y
Mol Immunol; 2023 Oct; 162():125-132. PubMed ID: 37677989
[TBL] [Abstract] [Full Text] [Related]
[Next]
